Related Experiment Video
Updated: Jun 4, 2026
07:08
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Doxepin concentrations in plasma and cerebrospinal fluid
Robert Schomburg1, Daniela Remane, Klaus Fassbender
1Department of Neurology, University of the Saarland, Kirrberger Straße, 66421, Homburg/Saar, Germany.
Journal of Neural Transmission (Vienna, Austria : 1996)
|February 26, 2011
Summary
Doxepin
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Therapeutics
Background:
- Antidepressant drugs (ADs), including doxepin, exhibit variable efficacy in patients.
- Pharmacokinetic factors, such as drug penetration into the cerebrospinal fluid (CSF), may explain treatment variability.
- Understanding drug concentrations in plasma and CSF is crucial for optimizing antidepressant therapy.
Purpose of the Study:
- To investigate the relationship between plasma and CSF concentrations of doxepin and its active metabolite, nordoxepin.
- To assess the correlation between drug dosage and its levels in plasma and CSF.
- To determine the consistency of doxepin's permeability into the CSF.
Main Methods:
- Simultaneous collection of plasma and CSF samples from 21 patients undergoing doxepin treatment.
- Quantification of doxepin and nordoxepin concentrations in both plasma and CSF.
- Statistical analysis, including Spearman's and Pearson's correlations, to assess relationships between variables.
Main Results:
- Significant correlations were observed between oral doxepin dosage and plasma concentrations of both doxepin and nordoxepin.
- Highly significant correlations were found between plasma and CSF concentrations for both doxepin and nordoxepin.
- These findings suggest consistent CSF permeability for doxepin and its metabolite.
Conclusions:
- Plasma concentrations of doxepin and nordoxepin are reliable indicators of their levels within the CSF.
- The consistent CSF permeability of doxepin and nordoxepin may contribute to predictable antidepressant effects.
- Further research can explore how these pharmacokinetic insights can personalize antidepressant treatment strategies.
More Related Videos
Related Concept Videos
01:23Drug Concentrations: Measurements
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Plasma —...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
01:15Drug Concentration Versus Time Correlation
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:25Dosage Regimen: Multiple Oral Dosage
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...